Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM[1]. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist[2].
Molecular Weight:
735.81
Purity:
99.44
CAS Number:
[412950-08-4]
Formula:
C40H38F5N3O3S
Target:
Phospholipase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted